异动解读 | Applied Therapeutics Inc.盘后大涨11.49% 财报利好加机构看好前景

异动解读08-14 06:14

Applied Therapeutics Inc.(APLT)今日盘后大涨11.49%,引发市场关注。根据最新财报数据,尽管该公司营收较低,但净利润达290万美元,每股收益0.02美元,市盈率为-4.27倍,财报数据利好或是推动股价上涨的一个原因。

更为重要的是,机构评级方面,所有6家参与评级的机构均给予该股买入评级,看好公司前景。Applied Therapeutics Inc.是一家临床阶段的生物制药公司,专注于开发针对罕见代谢疾病、糖尿病性心肌病和视网膜病变等高度未满足医疗需求的新型候选产品。机构对该公司前景的看好,以及公司在研产品管线的潜力,被视为推动股价大涨的主要原因。

不过,分析人士也指出,由于公司目前处于临床阶段,未来发展仍存在不确定性,投资者需审慎决策。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1191247976?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-14 06:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191247976","market":"hk","top_or_hot":-1,"title":"异动解读 | Applied Therapeutics Inc.盘后大涨11.49% 财报利好加机构看好前景","media":"异动解读","content":"<p>Applied Therapeutics Inc.(APLT)今日盘后大涨11.49%,引发市场关注。根据最新财报数据,尽管该公司营收较低,但净利润达290万美元,每股收益0.02美元,市盈率为-4.27倍,财报数据利好或是推动股价上涨的一个原因。</p>\n\n<p>更为重要的是,机构评级方面,所有6家参与评级的机构均给予该股买入评级,看好公司前景。Applied Therapeutics Inc.是一家临床阶段的生物制药公司,专注于开发针对罕见代谢疾病、糖尿病性心肌病和视网膜病变等高度未满足医疗需求的新型候选产品。机构对该公司前景的看好,以及公司在研产品管线的潜力,被视为推动股价大涨的主要原因。</p>\n\n<p>不过,分析人士也指出,由于公司目前处于临床阶段,未来发展仍存在不确定性,投资者需审慎决策。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Applied Therapeutics Inc.盘后大涨11.49% 财报利好加机构看好前景</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Applied Therapeutics Inc.盘后大涨11.49% 财报利好加机构看好前景\n</h2>\n\n<h4 class=\"meta\">\n\n2024-08-14 06:14 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Applied Therapeutics Inc.(APLT)今日盘后大涨11.49%,引发市场关注。根据最新财报数据,尽管该公司营收较低,但净利润达290万美元,每股收益0.02美元,市盈率为-4.27倍,财报数据利好或是推动股价上涨的一个原因。\n更为重要的是,机构评级方面,所有6家参与评级的机构均给予该股买入评级,看好公司前景。Applied Therapeutics Inc.是一家临床阶段的...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLT","symbol_name":"Applied Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1191247976","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191247976","pubTimestamp":1723587263,"sourceInfo":null,"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Applied Therapeutics Inc.今日盘后大涨11.49%,引发市场关注。根据最新财报数据,尽管该公司营收较低,但净利润达290万美元,每股收益0.02美元,市盈率为-4.27倍,财报数据利好或是推动股价上涨的一个原因。更为重要的是,机构评级方面,所有6家参与评级的机构均给予该股买入评级,看好公司前景。Applied Therapeutics Inc.是一家临床阶段的生物制药公司,专注于开发针对罕见代谢疾病、糖尿病性心肌病和视网膜病变等高度未满足医疗需求的新型候选产品。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"APLT":"Applied Therapeutics Inc."},"translate_title":"Interpretation of the change: Applied Therapeutics Inc. rose 11.49% after hours, with positive financial report and institutions optimistic about the prospects","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLT":1},"content_text":"Applied Therapeutics Inc.(APLT)今日盘后大涨11.49%,引发市场关注。根据最新财报数据,尽管该公司营收较低,但净利润达290万美元,每股收益0.02美元,市盈率为-4.27倍,财报数据利好或是推动股价上涨的一个原因。\n更为重要的是,机构评级方面,所有6家参与评级的机构均给予该股买入评级,看好公司前景。Applied Therapeutics Inc.是一家临床阶段的生物制药公司,专注于开发针对罕见代谢疾病、糖尿病性心肌病和视网膜病变等高度未满足医疗需求的新型候选产品。机构对该公司前景的看好,以及公司在研产品管线的潜力,被视为推动股价大涨的主要原因。\n不过,分析人士也指出,由于公司目前处于临床阶段,未来发展仍存在不确定性,投资者需审慎决策。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191247976"}